Enhanced Expression and Clinical Significance of Chemokine Receptor CXCR2 in Hepatocellular Carcinoma
Authors:
- 1 April 2011
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 166 (2) , 241-246
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Role of chemokines in tumor growthCancer Letters, 2007
- Targeting chemokines as a therapeutic option for hepatocellular carcinoma: A reality or just a fantasy?Journal of Gastroenterology and Hepatology, 2007
- The multifaceted roles of chemokines in malignancyCancer and Metastasis Reviews, 2006
- Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growthThe Prostate, 2006
- Chemokines in the Biology of Lung CancerJournal of Thoracic Oncology, 2006
- A Growth-Related Oncogene/CXC Chemokine Receptor 2 Autocrine Loop Contributes to Cellular Proliferation in Esophageal CancerCancer Research, 2006
- Chemokines inInnate andAdaptiveHostDefense: Basic Chemokinese Grammar for Immune CellsAnnual Review of Immunology, 2004
- Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinomaCancer, 2003
- Hepatocellular CarcinomaJournal of Clinical Gastroenterology, 2002
- Surgical resection for recurrent hepatocellular carcinoma: Prognosis and analysis of risk factorsSurgery, 1996